Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Johnston, Bradley C ^a   Thorlund, Kristian ^a   Schünemann, Holger J ^a   Xie, Feng ^a,b   Murad, Mohammad H ^c   Montori, Victor M ^c   Guyatt, Gordon H ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Programs for Assessment of Technology in Health Research Institute   (Canada)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY DISEASE QUESTIONNAIRE; CLINICAL TRIAL; CONFIDENCE INTERVAL; EFFECT SIZE; HUMAN; MEASUREMENT; META ANALYSIS; MINIMAL IMPORTANT DIFFERENCE UNIT; QUALITY OF LIFE; QUESTIONNAIRE; ST. GEORGES RESPIRATORY QUESTIONNAIRE; STANDARDIZED MEAN DIFFERENCE; SYSTEMATIC REVIEW;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; PSYCHOMETRICS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77957660942     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-116     Document Type: Article

References (22)

1. Angst F, Verra ML, Lehmann S, Aeschlimann A. Responsiveness of five condition-specific and generic outcome assessment instruments for chronic pain. BMC Med Res Methodol 2008, 8:26. 10.1186/1471-2288-8-26, 2386498, 18439285.
2. Wiebe S, Guyatt GH, Weaver B, Matijevic S, Sidwell C. Comparative Responsiveness of Generic and Specific Quality of Life Instruments. J Clin Epidemiol 2003, 56:52-60. 10.1016/S0895-4356(02)00537-1, 12589870.
3. Patient Reported Outcomes and Quality of Life Instruments Database Accessed September 27, 2010. , http://www.proqolid.org/proqolid/search__1/pathology_disease?pty=1924
4. Higgins JPT, Green S, . (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. (editors)., http://www.cochrane-handbook.org
5. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 1988, 25. Hillsdale, NJ: Lawrence Erlbaum Associates, second.
6. Fern E, Monroe K. Effect-size estimates: issues and problems in interpretation. J Consum Res 1996, 23:89-105.
7. Jaeschke R, Singer J, Guyatt GH. Measurement of Health Status: Ascertaining the Minimal Clinically Important Difference. Control Clin Trials 1989, 10:407-415. 10.1016/0197-2456(89)90005-6, 2691207.
8. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996, 49:1215-9. 10.1016/S0895-4356(96)00206-5, 8892486.
9. Schünemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement properties and interpretability of the chronic respiratory disease questionnaire (CRQ). COPD 2005, 2:81-9. 10.1081/COPD-200050651, 17136967.
10. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, . Clinical Significance Consensus Meeting Group Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002, 77:371-83. 10.4065/77.4.371, 11936935, Clinical Significance Consensus Meeting Group.
11. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, 18:CD003793.
12. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987, 42:773-8. 10.1136/thx.42.10.773, 460950, 3321537.
13. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-7.
14. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005, 2:75-9. 10.1081/COPD-200050513, 17136966.
15. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Ionescu AA, Thomas J, Tunbridge J. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000, 355:362-8. 10.1016/S0140-6736(99)07042-7, 10665556.
16. Puhan M, Guyatt GH, Goldstein R, Mador J, McKim D, Stahl E, Griffith L, Schünemann HJ. Relative responsiveness of the Chronic Respiratory Questionnaire St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respir Med 2007, 101(2):308-316. 10.1016/j.rmed.2006.04.023, 16782320.
17. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomised trials. BMJ 1998, 316:690-3. 1112685, 9522799.
18. Arbuckle RA, Humphrey L, Vardeva K, Arondekar B, Danten-Viala Msc M, Scott JA, Snoek FJ. Psychometric Evaluation of the Diabetes Symptom Checklist-Revised (DSC-R)-A Measure of Symptom Distress. Value Health 2009,
19. Barrett B, Brown R, Mundt M. Comparison of anchor-based and distributional approaches in estimating important difference in common cold. Qual Life Res 2008, 17:75-85. 10.1007/s11136-007-9277-2, 18027107.
20. Turner D, Schünemann HJ, Griffith LE, Beaton DE, Griffiths AM, Critch JN, Guyatt GH. The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol 2010, 63(1):28-36. 10.1016/j.jclinepi.2009.01.024, 19800198.
21. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999, 52:861-73. 10.1016/S0895-4356(99)00071-2, 10529027.
22. Puhan MA, Soesilo I, Guyatt GH, Schünemann HJ. Combining scores from different patient reported outcome measures in meta-analyses: when is it justified?. Health Qual Life Outcomes 2006, 4:94. 10.1186/1477-7525-4-94, 1712224, 17156420.